Skin regeneration is accelerated by a lower dose of multipotent mesenchymal stromal/stem cells—a paradigm change

BACKGROUND: Multipotent mesenchymal stromal/stem cell (MSC) therapy is under investigation in promising (pre-)clinical trials for wound healing, which is crucial for survival; however, the optimal cell dosage remains unknown. The aim was to investigate the efficacy of different low-to-high MSC dosag...

Descripción completa

Detalles Bibliográficos
Autores principales: Eylert, Gertraud, Dolp, Reinhard, Parousis, Alexandra, Cheng, Richard, Auger, Christopher, Holter, Magdalena, Lang-Olip, Ingrid, Reiner, Viola, Kamolz, Lars-Peter, Jeschke, Marc G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831169/
https://www.ncbi.nlm.nih.gov/pubmed/33494813
http://dx.doi.org/10.1186/s13287-020-02131-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831169/
https://www.ncbi.nlm.nih.gov/pubmed/33494813
http://dx.doi.org/10.1186/s13287-020-02131-6

Ejemplares similares